Revium Rx (RVRC) Common Equity (2024 - 2025)
Revium Rx (RVRC) reported Common Equity of $6.9 million for Q4 2025, down 65.08% on a YoY basis from $19.7 million in Q4 2024, and down 65.08% sequentially from $19.7 million in Q4 2024.
Revium Rx (RVRC) Common Equity (2024 - 2025) Analysis & Trends
Revium Rx (RVRC) has 2 years of Common Equity data on file, last reported at $6.9 million in Q4 2025.
- For the quarter ending Q4 2025, Common Equity fell 65.08% year-over-year to $6.9 million; the trailing twelve-month figure through Dec 2025 stood at $6.9 million (down 65.08% YoY), and the FY2025 full-year result was $6.9 million, down 65.08% from the prior year.
- Common Equity declined to $6.9 million in Q4 2025, from $19.7 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $19.7 million in Q4 2024 to a low of $6.9 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 29.34 Bn | 22.03 Bn | 662.02 Mn | 7.30 Bn |
| 2 | BrightSpring Health Services | 13.49 Bn | 12.59 Bn | 482.22 Mn | 1.98 Bn |
| 3 | Healthequity | 7.96 Bn | 7.70 Bn | 256.31 Mn | 2.05 Bn |
| 4 | 10x Genomics | 6.17 Bn | 5.63 Bn | 106.18 Mn | 814.32 Mn |
| 5 | Hinge Health | 6.02 Bn | 5.70 Bn | 154.23 Mn | 111.69 Mn |
| 6 | MiniMed | 4.19 Bn | 3.89 Bn | 480.00 Mn | 3.61 Bn |
| 7 | Waystar Holding | 4.14 Bn | 4.07 Bn | 216.84 Mn | 3.94 Bn |
| 8 | Doximity | 3.82 Bn | 3.08 Bn | 125.97 Mn | 950.84 Mn |
| 9 | Privia Health | 3.10 Bn | 2.73 Bn | - | 805.90 Mn |
| 10 | Revium Rx | 101.42 Mn | 98.71 Mn | - | 6.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.88 Mn |
| Dec 31, 2024 | 19.71 Mn |